Zhejiang Medicine Co Ltd - Company Profile
Powered by
All the data and insights you need on Zhejiang Medicine Co Ltd in one report.
- Save hours of research time and resources with
our up-to-date Zhejiang Medicine Co Ltd Strategy Report
- Understand Zhejiang Medicine Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Zhejiang Medicine Co Ltd (Zhejiang Medicine) develops, manufactures, and commercializes biological drugs, pharmaceutical intermediates, and bio-pesticides. The company's product portfolio consists of animal nutrition, active pharmaceutical ingredients (APls) and intermediates; antibiotics and human nutrition products including vitamin E, natural vitamin E, vitamin A, vitamin D3 and other pharmaceutical preparations. The company provides its products in large and small volume injections, freeze dried powder injections, tablets, hard and soft capsules, pills and oral solutions. It has two research and development centers, namely, Shaoxing Research Institute of Pharmaceutical Industry and Shanghai Health Creation Biological Drug Research and Development Center. Zhejiang Medicine is headquartered in Shaoxing, Zhejiang, China.
Zhejiang Medicine Co Ltd premium industry data and analytics
Products and Services
Products |
---|
- |
Pharmaceuticals |
Fine Chemicals |
XYZ |
XYZ |
XYZ |
Competitor Comparison
Key Parameters | Zhejiang Medicine Co Ltd | Sinopharm Group Co Ltd | China Meheco Group Co Ltd | Zhejiang NHU Co Ltd | North China Pharmaceutical Co Ltd |
---|---|---|---|---|---|
Headquarters | China | China | China | China | China |
City | Shaoxing | Shanghai | Beijing | Shaoxing | Shijiazhuang |
State/Province | Zhejiang | Shanghai | Beijing | Zhejiang | Hebei |
No. of Employees | 6,208 | 113,362 | 8,313 | 11,526 | 10,952 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Chunbo Li | Chairman | Executive Board | 2009 | 64 |
Li Qirong | Chief Financial Officer | Senior Management | 2021 | 35 |
Yin Zhifeng | Vice Chairman | Executive Board | 2021 | 45 |
Li Nanhang | Vice Chairman; Vice President | Executive Board | 2021 | 37 |
Lu Chunlei | Vice Chairman; President | Executive Board | 2021 | 56 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward